Actor and producer Nikhil Dwivedi, who bankrolled films like Salman Khan's Dabangg 3 and Kareena Kapoor Khan and Sonam Kapoor's Veere Di Wedding, has been tested positive for COVID-19.
Actor and producer Nikhil Dwivedi, who bankrolled films like Salman Khan's Dabangg 3 and Kareena Kapoor Khan and Sonam Kapoor's Veere Di Wedding, has been tested positive for COVID-19.
Paris [France], December 1 (ANI/Xinhua): France on Monday registered 4,005 confirmed cases of COVID-19 and 406 deaths from the disease in the last 24 hours, while the number of hospitalized patients continued a downward trend, data released by health authorities showed.
President-elect Joe Biden's pick to lead the Office of Management and Budget is quickly emerging as a political battle that could disrupt his efforts to swiftly fill out his administration. “Neera Tanden, who has an endless stream of disparaging comments about the Republican Senators’ whose votes she’ll need, stands zero chance of being confirmed,” tweeted Drew Brandewie, communications director for Republican Sen. John Cornyn of Texas.
The day before Thanksgiving, also known as Turkey Wednesday — a normally hectic grocery store day for last minute shoppers — saw a significant decrease in foot traffic compared to 2019 levels, according to data compiled by analytics research firm Placer.ai.
Shareholder rights law firm Robbins LLP announces that a purchaser of K12 Inc. (NYSE:LRN) filed a class action complaint against the Company and its officers and directors for alleged violations of the Securities & Exchange Act of 1934 between April 27, 2020 and September 18, 2020. K12 is a technology-based education company that provides online content and educational services worldwide.
JOHNSTOWN, Ontario, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Purplefarm Genetics Inc. a cannabis company in Johnstown, Ontario, is proud to announce that it has been awarded licenses from Health Canada pursuant to the Cannabis Act for Cultivation, Processing, and Federal Medical Sales. These licenses represent a major step forward for the company, as it will enable operations to begin immediately in its state-of-the-art indoor cannabis facility, situated on a 5-acre property in Eastern Ontario. Purplefarm Genetics’ focus is to grow unique cultivars for the Canadian medical and recreational market: cultivars that are consistently cannabinoid and terpene rich. With a commitment to transparency and cultivation excellence, the Purplefarm Genetics’ team is excited to share with the Canadian market what can be achieved with cannabis flower when no shortcuts are taken.“We are indebted to the activists and trailblazers that helped to create this new legal market. In this same vein, we are excited to introduce something new to Canadian patients and consumers” said Mitchell Alswiti, Founder of Purplefarm Genetics. “Purplefarm will be producing rich, differentiated cannabis cultivars unlike anything the market has seen to date. Product that will never be irradiated or diminished in quality before being placed in the hands of the consumer.”“Our commitment to transparency, sustainability and cultivation excellence is at the core of our philosophy” said Jonah Clifford, Director and Responsible Person for Purplefarm Genetics. “It is these commitments that drive our actions: from our decision to be the first zero-material waste facility, to our partnership and research collaborations that drive the whole industry forward.”ABOUT PURPLEFARM GENETICS INC.Purplefarm Genetics is privately-owned Licensed Producer focusing on differentiated, non-irradiated cannabis products. This focus allows them to bring extra-ordinary products into an increasingly homogenous cannabis market. With an uncompromising commitment to both indoor-grown quality and sustainable practices, Purplefarm Genetics is taking no shortcuts in producing whole flower cannabis for Canadian patients and consumers. To learn more, visit their website at purplefarmgenetics.com. CONTACT: Contact: Purplerfarm Genetics Jonah Clifford Phone: +1 613-552-9553 firstname.lastname@example.org
MIAMI, Nov. 30, 2020 (GLOBE NEWSWIRE) -- ShiftPixy, Inc. (NASDAQ: PIXY), a Florida-based staffing enterprise that designs, manages, and sells access to a disruptive, revolutionary platform that facilitates employment in the rapidly growing Gig Economy, today announced operating results for the year ended August 31, 2020 (“2020”). 2020 Financial Highlights * Improved balance sheet compared to the fiscal year ended August 31, 2019 (“2019”): * Eliminated debt with full-ratchet anti-dilution price protection during 2020 * Raised over $25 million in equity from May 2020 to October 2020 * Sold 85% of lower growth business which generated $9.5 million of cash * Quarterly gross billings improved to $18.7 million for Q4 2020, a sequential increase of $4.3 million or 30% from Q3 2020, due to new customer additions and COVID-19 recovery for existing customers. For the entire fiscal year, gross billings from continuing operations were $66 million, compared to $73 million for 2019, due primarily to COVID-19 impacts in 2020, as well as client cancellations primarily in the early part of 2020, during calendar 2019. * Quarterly revenues improved to $2.4 million for Q4 2020, a sequential increase of 20% from Q3 2020. Revenues for the entire fiscal year decreased 17% to $8.6 million, compared to $10.5 million for 2019, primarily as a result of our strategic decision to shift our client focus during 2019, as well as the negative impact of COVID-19 growth headwinds. * Gross profit for 2020 was $1.0 million, decreasing 50% from 2019 gross profit of $1.9 million, due to workers’ compensation cost increases. * Loss from Operations for 2020 increased $6.0 million to $21.6 million from $15.6 million in 2019, of which $3.5 million was a non-cash asset impairment charge related to previously capitalized software, along with a $1.0 million increase in stock-based compensation. * EBITDAS Loss (Operating Loss excluding asset impairment, interest expense, depreciation, amortization and share-based compensation) increased to $16.2 million for 2020 from $14.7 million for 2019 due to $1.0 million of reduced margins and increased spending on our mobile application development, offset by decreased operations costs. * Investment in our mobile application and technology solution deployment increased to $4.2 million in 2020 from $3.1 million in 2019. Total Human Resource Information System (“HRIS”) and mobile application investment is $20.7 million to date.2020 Operational Highlights * The number of employees retained in our employee HRIS exceeded 35,000. * Relocated corporate headquarters to Miami, Florida to expand sales and marketing reach to better serve Eastern United States and Latin America (move substantially completed in September 2020). * Experienced billings and worksite employee growth during 2020 despite COVID-19 pandemic due to new client additions and Q4 COVID-19 recovery. * New partnership established in Q4 2020 that has the potential to bring over 200,000 new restaurant employees onto our HRIS platform, with the added potential to generate gross wage billings of $20,000 per employee. * New nationwide nurse staffing client signed in Q4 2020 with over 8,000 employees that has the potential to generate gross billings of approximately $50,000 per employee, which we expect to drive significant revenue and gross profit growth. * Full suite of mobile application and HRIS platform functionality nearing completion and full commercial launch, which we expect to add additional revenue streams.“2020 was a key transition year for ShiftPixy. We completed the client refocus we began in 2019 away from light industrial clients to quick service restaurants and other new business opportunities that we believe are better served by our new technology platform. We significantly improved our balance sheet by selling assets and raising additional capital which allowed us to eliminate our convertible debt and continue to invest in our growth initiatives. Despite setbacks in our May 31, 2020 quarter due to the COVID-19 pandemic, at year end the combined recovery of our pre-COVID business combined with our new customer additions resulted in sequential billing growth that continues into our first fiscal quarter of 2021,” stated Chief Executive Officer Scott Absher. “We are starting to see customer on-boarding from sales wins by our new sales team in our new Miami headquarters and are very excited about our new partnerships in the State of Washington and our new nurse staffing client, both of which we believe will drive revenue and gross profit growth in the first half of Fiscal 2021. We believe that we are well positioned to execute on these recent wins and expect to see a significant increase in our business activity levels. We hope to achieve profitability in the second half of Fiscal 2021 as we continue our focus on creating long-term shareholder value.”About ShiftPixyShiftPixy is a disruptive human capital services enterprise, revolutionizing employment in the Gig Economy by delivering a next-gen platform for workforce management that helps businesses with shift-based employees navigate regulatory mandates, minimize administrative burdens and better connect with a ready-for-hire workforce. With expertise rooted in management’s nearly 25 years of workers’ compensation and compliance programs experience, ShiftPixy adds a needed layer for addressing compliance and continued demands for equitable employment practices in the growing Gig Economy. ShiftPixy’s complete human capital management ecosystem is designed to manage regulatory requirements and compliance in such required areas as paid time off (PTO) laws, insurance and workers’ compensation, minimum wage increases, and Affordable Care Act (ACA) compliance.ShiftPixy Cautionary StatementThe information provided in this release includes forward-looking statements, the achievement or success of which involves risks, uncertainties, and assumptions. These forward-looking statements are made pursuant to the safe harbor provisions within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Although such forward-looking statements are based upon what our management believes are reasonable assumptions, there can be no assurance that forward-looking statements will prove to be accurate. If any of the risks or uncertainties, including those set forth below, materialize or if any of the assumptions proves incorrect, our results could differ materially from the results expressed or implied by the forward-looking statements we make. The risks and uncertainties include, but are not limited to, risks associated with the nature of our business model; our ability to execute our vision and growth strategy; our ability to attract and retain clients; our ability to assess and manage risks; changes in the law that affect our business and our ability to respond to such changes and incorporate them into our business model, as necessary; our ability to insure against and otherwise effectively manage risks that affect our business; risks arising from the COVID-19 pandemic or any other events that could cause wide-scale business disruptions; competition; reliance on third-party systems and software; our ability to protect and maintain our intellectual property; and general developments in the economy and financial markets. These and other risks are discussed in our filings with the Securities and Exchange Commission (the “SEC”), including, without limitation, our Annual Report on Form 10-K, filed on November 30, 2020, our Quarterly Reports on Form 10-Q and our Current Reports on Form 8-K. These documents, including the sections therein entitled “Risk Factors,” identify important factors that could cause actual results to differ materially from those contained in forward-looking statements. All of our forward-looking statements are expressly qualified by all such risk factors and other cautionary statements. Statements made in connection with any guidance may refer to financial statements that have not been reviewed or audited. We undertake no obligation to update forward-looking statements if circumstances or management's estimates or opinions should change, except as required by applicable securities laws. The information in this press release shall not be deemed to be "filed" for the purpose of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, and will not be deemed an admission as to the materiality of any information that is required to be disclosed solely by Regulation FD. Further information on these and other factors that could affect our financial results is included in the filings we make with the SEC from time to time. These documents are available on the "SEC Filings" subsection of the "Investor Information" section of our website at https://ir.shiftpixy.com/financial-information/sec-filings, or directly from the SEC’s website at https://www.sec.gov.Consistent with the SEC’s April 2013 guidance on using social media outlets like Facebook and Twitter to make corporate disclosures and announce key information in compliance with Regulation FD, we are alerting investors and other members of the general public that we will provide updates on operations and progress required to be disclosed under Regulation FD through the Company’s social media on Facebook, Twitter, LinkedIn and YouTube. Investors, potential investors, shareholders and individuals interested in us are encouraged to keep informed by following us on Facebook, Twitter, LinkedIn and YouTube.INVESTOR CONTACT: InvestorRelations@shiftpixy.com 800.475.3655ShiftPixy, Inc. Consolidated Balance Sheets August 31, 2020 August 31, 2019 ASSETS Current assets Cash $4,303,000 $1,561,000 Accounts receivable, net 308,000 85,000 Unbilled accounts receivable 2,303,000 1,418,000 Deposit – workers’ compensation 293,000 235,000 Prepaid expenses 723,000 349,000 Other current assets 73,000 244,000 Current assets of discontinued operations 1,030,000 10,139,000 Total current assets 9,033,000 14,031,000 Fixed assets, net 575,000 4,155,000 Note receivable, net 4,045,000 - Deposits – workers’ compensation 736,000 754,000 Deposits and other assets 449,000 124,000 Non-current assets of discontinued operations 2,582,000 5,567,000 Total assets $17,420,000 $24,631,000 LIABILITIES AND STOCKHOLDERS’ DEFICIT Current liabilities Accounts payable and other accrued liabilities $3,831,000 $4,454,000 Payroll related liabilities 5,752,000 2,559,000 Convertible notes, net - 3,351,000 Accrued workers’ compensation costs 497,000 235,000 Default penalties accrual - 1,800,000 Derivative liability - 3,756,000 Current liabilities of discontinued operations 1,746,000 16,033,000 Total current liabilities 11,826,000 32,188,000 Non-current liabilities Accrued workers’ compensation costs 1,247,000 525,000 Non-current liabilities of discontinued operations 4,377,000 3,853,000 Total liabilities 17,450,000 36,566,000 Commitments and contingencies Stockholders’ deficit Preferred stock, 50,000,000 authorized shares; $0.0001 par value - - Common stock, 750,000,000 authorized shares; $0.0001 par value; 16,902,146 and 909,222 shares issued as of August 31, 2020 and 2019 1,000 - Additional paid-in capital 119,431,000 32,505,000 Treasury stock, at cost-0 and 13,953 shares as of August 31, 2020 and August 31, 2019 - (325,000) Accumulated deficit (119,462,000) (44,115,000) Total stockholders’ deficit (30,000) (11,935,000) Total liabilities and stockholders’ deficit $17,420,000 $24,631,000 ShiftPixy Inc. Consolidated Statements of Operations For the year ended August 31, 2020 August 31, 2019 Revenues (gross billings of $65.5 million and $73.4 million less worksite employee payroll cost of $56.9 million and $62.9 million, respectively) $8,642,000 $10,451,000 Cost of revenue 7,685,000 8,538,000 Gross profit 957,000 1,913,000 Operating expenses: Salaries, wages, and payroll taxes 7,227,000 6,283,000 Stock-based compensation – general and administrative 1,526,000 632,000 Commissions 181,000 201,000 Professional fees 3,366,000 3,918,000 Software development - external 2,240,000 1,209,000 Depreciation and amortization 272,000 194,000 Impaired asset expense 3,543,000 - General and administrative 4,180,000 5,032,000 Total operating expenses 22,535,000 17,469,000 Operating Loss (21,578,000) (15,556,000) Other (expense) income: Interest expense (2,525,000) (8,507,000) Change in fair value of note receivable (1,074,000) - Expense related to Preferred Options (62,091,000) - Expense related to modification of warrants (21,000) - Loss from debt conversion (3,500,000) - Inducement loss (624,000) (3,927,000) Loss on debt extinguishment (1,592,000) - Change in fair value derivative and warrant liability 1,777,000 2,569,000 Loss on convertible note settlement - 811,000 Gain on convertible note penalties accrual 760,000 - Total other (expense) income (68,890,000) (9,054,000) Loss from continuing operations (90,468,000) (24,610,000) (Loss) Income from discontinued operations (Loss) Income from discontinued operations (561,000) 6,528,000 Gain from asset sale 15,682,000 - Total Income (Loss) from discontinued operations, net of tax 15,121,000 6,528,000 Net loss $(75,347,000) $(18,082,000) Net Loss per share, Basic and diluted Continuing operations $(4.96) $(30.09) Discontinued operations Operating (loss) income (0.03) 7.98 Gain on sale of assets 0.86 - Total discontinued operations 0.83 7.98 Net Loss per share of common stock – Basic and diluted $(4.13) $(22.11) Weighted average common stock outstanding – Basic and diluted 18,222,661 817,720
Bitcoin soared to a record high against the dollar on Monday, as its 2020 rally steamed ahead. The digital unit touched an all-time peak of $19,864.15, breaking its prior record set nearly three years ago. Bitcoin overall has gained more than 170% this year, fueled by a demand for riskier assets amid unprecedented fiscal and monetary stimulus, hunger for assets perceived as resistant to inflation, and expectations that cryptocurrencies would win mainstream acceptance. Bitcoin's 12-year history has been peppered with steep gains and equally sharp drops. Compared to traditional assets, its market is highly opaque. But analysts say the bitcoin market has evolved since 2017, now boasting a functioning derivatives market and custody services by major financial firms.
The voting stage has begun on this year’s show
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.Oslo, 30 November 2020. Reference is made to the stock exchange release from Saga Pure ASA ("SAGA " or the "Company") published on 30 October 2020 regarding a contemplated private placement (the "Private Placement"). The Company is pleased to announce that it has raised NOK 54.4 million in gross proceeds through the Private Placement of 34,000,000 new shares (the "Offer Shares"), at a price per share of NOK 1.60 (the "Subscription Price"). Fearnley Securities AS acted as Sole Manager and Bookrunner (the "Manager") for the Private Placement. The Private Placement was well oversubscribed. The net proceeds from the Private Placement will be used to strengthen the Company's investment capacity in the green investment universe and for general corporate purposes. Notification of allotment of the Offer Shares including settlement instructions will be sent to the applicants through a notification from the Manager on or about 1 December 2020. Settlement for the Private Placement is expected to be on or about 3 December 2020 (DVP, T+2). The delivery of New Shares will be settled with existing and unencumbered shares in the Company that are already listed on the Euronext Expand, pursuant to a share lending agreement between the Manager and the Company's largest shareholder, Øystein Stray Spetalen. Accordingly, the shares delivered to the investors will be tradable upon delivery. In order to settle the share loan, the Company's Board of Directors has resolved to issue 34,000,000 new shares in the Company pursuant to an authorisation granted by the Company's annual general meeting. Consequently, the share capital of the Company will be increased with NOK 340,000. Following registration of the Private Placement, the Company will have 374,149,831 shares outstanding, each with a par value of NOK 0.01. The Board of the Company has resolved to not carry out a subsequent offering, as the Subscription Price provides only a modest discount to the closing price of the Company's shares on 30 November 2020 and a significant premium to the average trading price of the Company's shares during the last 30, 60 and 90 day periods. The waiver of the preferential rights inherent in a private placement is considered necessary in the interest of time and successful completion of the Private Placement. Taking into consideration the time, costs and expected terms of alternative methods of the securing the desired funding, the Board has concluded that the completion of the Private Placement on the proposed terms at this time is in the mutual interest of the Company and its shareholders, and considers that the Private Placement complies with the equal treatment obligations under the Norwegian Securities Trading Act and the Oslo Stock Exchange's Circular no. 2/2014. Advokatfirmaet CLP DA acts as Norwegian legal counsel to the Company in connection with the Private Placement. For additional information, please contact: Espen Lundaas, CEO, +47 924 31 417, e-mail: Espen@ferncliff.no (mailto:Espen@ferncliff.no) Martin Nes, Chairman, +47 920 14 814, e-mail: Martin@ferncliff.no (mailto:Martin@ferncliff.no)This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act
UDR, Inc. (the "Company") (NYSE: UDR), announced today that it has priced an offering of $350 million aggregate principal amount of 1.900% senior unsecured medium-term notes due March 15, 2033. The notes were priced at 99.578% of the principal amount, plus accrued interest from December 14, 2020 to yield 1.939% to maturity.
VMware, Inc. (NYSE: VMW), a leading innovator in enterprise software, today announced that Pat Gelsinger, VMware’s chief executive officer, will present as a keynote speaker at the Barclays Global TMT conference on Wednesday, December 9, 2020 at 11:00 a.m. PT/ 2:00 p.m. ET.
Principal Financial Group elevates two regional Principal International leaders to executive team; president & CEO of Principal International retires
Today, Walmart announced Dr. Cheryl Pegus as Walmart’s Executive Vice President, Health & Wellness. In this role, Dr. Pegus will further develop Walmart’s bold healthcare vision, leading health and wellness across the Walmart enterprise. Dr. Pegus will report to Walmart U.S. CEO John Furner, and her first day with Walmart will be Dec. 21st.
PGIM High Yield Bond Fund, Inc. (NYSE: ISD) and PGIM Global High Yield Fund, Inc. (NYSE: GHY) declared today monthly distributions for December 2020, January and February 2021. The distribution amounts and schedule for each fund appears below:
TAMPA, Fla., Nov. 30, 2020 (GLOBE NEWSWIRE) -- BRP Group, Inc. (“BRP Group” or the “Company”) (NASDAQ: BRP), a rapidly growing independent insurance distribution firm delivering tailored insurance solutions, today announced Baldwin Krystyn Sherman Partners, LLC (“BKS”), the middle-market subsidiary of BRP Group, completed the previously announced acquisition of Insgroup, Inc. (which converted prior to closing to a limited liability company with the name Insgroup, LLC). ABOUT BRP GROUP, INC.BRP Group, Inc. (NASDAQ: BRP) is a rapidly growing independent insurance distribution firm delivering tailored insurance and risk management insights and solutions that give our clients the peace of mind to pursue their purpose, passion and dreams. We are innovating the industry by taking a holistic and tailored approach to risk management, insurance and employee benefits, and support our clients, Colleagues, Insurance Company Partners and communities through the deployment of vanguard resources and capital to drive our growth. BRP represents over 500,000 clients across the United States and internationally. For more information, please visit www.baldwinriskpartners.com. Learn more about BKS Partners at www.bks-partners.com.NOTE REGARDING FORWARD-LOOKING STATEMENTSThis press release may contain various “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, which represent BRP Group’s expectations or beliefs concerning future events. Forward-looking statements are statements other than historical facts and may include statements that address future operating, financial or business performance or BRP Group’s strategies or expectations, including about this Partnership. In some cases, you can identify these statements by forward-looking words such as “may”, “might”, “will”, “should”, “expects”, “plans”, “anticipates”, “believes”, “estimates”, “predicts”, “projects”, “potential”, “outlook” or “continue”, or the negative of these terms or other comparable terminology. Forward-looking statements are based on management’s current expectations and beliefs and involve significant risks and uncertainties that could cause actual results, developments and business decisions to differ materially from those contemplated by these statements.Factors that could cause actual results or performance to differ from the expectations expressed or implied in such forward-looking statements include, but are not limited to, those described under the caption “Risk Factors” in BRP Group’s Annual Report on Form 10-K for the year ended December 31, 2019, BRP Group’s Quarterly Report on Form 10-Q for the three months ended March 31, 2020, and BRP Group’s other filings with the SEC, which are available free of charge on the Securities and Exchange Commission's website at: www.sec.gov, including those risks and other factors relevant to BRP Group’s integration of this Partnership, matters assessed in BRP Group’s due diligence, risks related to the disruption of management time from ongoing business operations due to this Partnership, the business, financial condition and results of operations of BRP Group or this Partner, or both, and factors related to the potential effects of the COVID-19 pandemic on BRP Group’s business, financial condition and results of operations. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated. All forward-looking statements and all subsequent written and oral forward-looking statements attributable to BRP Group or to persons acting on behalf of BRP Group are expressly qualified in their entirety by reference to these risks and uncertainties. You should not place undue reliance on forward-looking statements. Forward-looking statements speak only as of the date they are made, and BRP Group does not undertake any obligation to update them in light of new information, future developments or otherwise, except as may be required under applicable law.CONTACTSINVESTOR RELATIONS Investor Relations (813) 259-8032 | IR@baldwinriskpartners.comPRESSRachel Carr, Marketing Director Baldwin Risk Partners (813) 418-5166 | Rachel.Carr@baldwinriskpartners.com
CHANDLER, Ariz., Nov. 30, 2020 (GLOBE NEWSWIRE) -- (NASDAQ:MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected and secure embedded control solutions, announced today that the Company will present at the 43rd Nasdaq Investor Conference on Thursday, December 3, 2020, at 8:00 a.m. (Eastern Time). Presenting for the Company will be Mr. Eric Bjornholt, Senior Vice President and Chief Financial Officer. A live webcast of the presentation will be made available by Wells, and can be accessed on the Microchip website at www.microchip.com. Any forward looking statements made during the presentation are qualified in their entirety by the discussion of risks set forth in the Company's Securities and Exchange Commission filings. Copies of SEC filings can be obtained for free at the SEC's website (www.sec.gov) or from commercial document retrieval services.Microchip Technology Incorporated is a leading provider of smart, connected and secure embedded control solutions. Its easy-to-use development tools and comprehensive product portfolio enable customers to create optimal designs, which reduce risk while lowering total system cost and time to market. The company's solutions serve more than 120,000 customers across the industrial, automotive, consumer, aerospace and defense, communications and computing markets. Headquartered in Chandler, Arizona, Microchip offers outstanding technical support along with dependable delivery and quality. For more information, visit the Microchip website at www.microchip.com.Note: The Microchip name and logo are registered trademarks of Microchip Technology Inc. in the USA and other countries.INVESTOR RELATIONS CONTACT: Deborah Wussler (480) 792-7373
REDWOOD CITY, Calif., Nov. 30, 2020 (GLOBE NEWSWIRE) -- Talend (NASDAQ: TLND), a global leader in data integration and data integrity, today announced that its management team will be participating in the following conferences: Barclays Global Technology, Media and Telecommunications Conference Wednesday, December 9, 2020 Presentation Time: 8:00 am PT / 11:00 am ETNeedham 23rd Annual Virtual Growth Conference Tuesday, January 12, 2021 Presentation Time: 11:45 am PT / 2:45 pm ETThe presentations will be webcast live and archived on Talend's investor relations website at http://investor.talend.com. The replays of the presentations will be available on the website for at least 30 days.About Talend Talend (NASDAQ: TLND), a leader in data integration and data integrity, is changing the way the world makes decisions. Talend Data Fabric is the only platform that brings together all the data integration and governance capabilities to simplify every aspect of working with data. Talend delivers complete, clean, and uncompromised data in real-time to all. This unified approach to data has made it possible to create the Talend Trust Score™, an industry-first innovation that instantly assesses the reliability of any dataset to bring clarity and confidence to every decision. Over 5000 organizations across the globe have chosen Talend to run their businesses on trusted data. Talend is recognized as a leader in its field by leading analyst firms and industry media. For more information, please visit www.talend.com and follow us on Twitter: @Talend. Investor Contact: The Blueshirt Group for Talend Lisa Laukkanen or Lauren Sloane, 415-217-2632 email@example.comMedia Contact: Chris Taylor, 408 674-1238 Vice President, Corporate Communications firstname.lastname@example.org
VANCOUVER, British Columbia and SEATTLE, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (NASDAQ: KDNY), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced that the Compensation Committee of the Company’s Board of Directors approved a new employment inducement grant of stock options to purchase a total of 147,477 shares of common stock with a grant date of November 30, 2020 (the “Inducement Grant”) for Eric Bjerkholt, the Company’s chief financial officer. The stock options approved under the Inducement Grant were issued on terms substantially similar to Chinook’s 2015 Equity Incentive Plan and have an exercise price per share equal to $13.98, the closing price per share of Chinook’s common stock on the grant date. The stock options vest over four years, with 25% vesting on November 16, 2021 and 1/36th of the remaining shares vesting monthly thereafter, subject to Mr. Bjerkholt’s continued employment on each such date. The stock options have a 10-year term and are subject to the terms and conditions of the stock option agreement.The Company granted the stock options as a material inducement to Mr. Bjerkholt for entering into employment with Chinook Therapeutics, Inc. in accordance with Nasdaq listing Rule 5635(c)(4).About Chinook Therapeutics, Inc. Chinook Therapeutics, Inc. is a clinical-stage biotechnology company developing precision medicines for kidney diseases. Chinook’s product candidates are being investigated in rare, severe chronic kidney disorders with opportunities for well-defined clinical pathways. Chinook’s lead program is atrasentan, an investigational Phase 3-ready endothelin receptor antagonist for the treatment of IgA nephropathy and other primary glomerular diseases. BION-1301, an investigational anti-APRIL monoclonal antibody is being evaluated in a Phase 1b trial for IgA nephropathy. In addition, Chinook is advancing CHK-336, a small-molecule preclinical development candidate for the treatment of primary hyperoxaluria, as well as research programs for other rare, severe chronic kidney diseases, including polycystic kidney disease. Chinook is building its pipeline by leveraging insights in kidney single cell RNA sequencing, human-derived organoids and new translational models, to discover and develop therapeutics with differentiating mechanisms of action against key kidney disease pathways. To learn more, visit www.chinooktx.com.Contact: Noopur Liffick Vice President, Investor Relations & Corporate Communications 510-809-2465 email@example.com firstname.lastname@example.org
Barclays Bank PLC ("Barclays") announced today that it will exercise its issuer call option and redeem, in full, each series of exchange-traded notes listed in the table below (each, an "ETN" and collectively, the "ETNs"). Further details regarding the redemption of these ETNs are highlighted in the table below:
Arco Platform Limited, or Arco (Nasdaq: ARCE), today reported financial and operating results for the third quarter of 2020 ended September 30th, 2020.